Matches in Wikidata for { <http://www.wikidata.org/entity/Q65544175> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q65544175 description "clinical trial" @default.
- Q65544175 description "ensayu clínicu" @default.
- Q65544175 description "klinisch onderzoek" @default.
- Q65544175 description "клінічне випробування" @default.
- Q65544175 name "A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients" @default.
- Q65544175 name "A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients" @default.
- Q65544175 type Item @default.
- Q65544175 label "A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients" @default.
- Q65544175 label "A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients" @default.
- Q65544175 prefLabel "A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients" @default.
- Q65544175 prefLabel "A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients" @default.
- Q65544175 P1050 Q65544175-A5F862DE-5AA6-4B08-9800-DE2CC7488D7D @default.
- Q65544175 P1132 Q65544175-4D6DD40D-34BE-4450-883F-FB6F9464CB36 @default.
- Q65544175 P1476 Q65544175-F95C4B4D-FCE2-498D-A7DB-18B5588BC2D6 @default.
- Q65544175 P17 Q65544175-4C5B2898-C6A2-40A8-87E5-9CCCAB42AF19 @default.
- Q65544175 P17 Q65544175-9B7CC8AE-C774-4916-A652-C1061AE03E17 @default.
- Q65544175 P2899 Q65544175-95238E45-78A4-4CE9-ACAE-ECDCA581D7B8 @default.
- Q65544175 P3098 Q65544175-31818C60-674B-4946-AB76-15F6BC2209BE @default.
- Q65544175 P31 Q65544175-DADC0036-D71E-47AF-ACBF-3BD9A5AD9E75 @default.
- Q65544175 P4844 Q65544175-41466A3B-C05C-4929-859C-EDE928739643 @default.
- Q65544175 P580 Q65544175-8918EA36-0CE8-4E2E-A6F8-97D600D5C46C @default.
- Q65544175 P582 Q65544175-44ADEDDD-60CD-48EB-94CA-EEA4F8CED5BA @default.
- Q65544175 P6099 Q65544175-900CA56C-A565-47B4-8B30-1E5A18626C85 @default.
- Q65544175 P6153 Q65544175-D63DE853-AC3A-4690-A991-2C4D62B8DB64 @default.
- Q65544175 P8363 Q65544175-63B74C5B-FEAC-44C4-BB02-392EFDA881A4 @default.
- Q65544175 P1050 Q41861 @default.
- Q65544175 P1132 "+641" @default.
- Q65544175 P1476 "An Eight Week, Multicenter Study to Evaluate Efficacy and Safety of the Triple Combo of Aliskiren /Valsartan/HCTZ (300/320/25 mg), Compared to the Double Combos of Aliskiren/HCTZ (300/25 mg) or Valsartan/HCTZ (320/25 mg) in Patients With Essential Hypertension Not Adequately Responsive to HCTZ 25 mg" @default.
- Q65544175 P17 Q183 @default.
- Q65544175 P17 Q30 @default.
- Q65544175 P2899 "+18" @default.
- Q65544175 P3098 "NCT00219193" @default.
- Q65544175 P31 Q30612 @default.
- Q65544175 P4844 Q7912612 @default.
- Q65544175 P580 "2005-10-01T00:00:00Z" @default.
- Q65544175 P582 "2007-01-01T00:00:00Z" @default.
- Q65544175 P6099 Q42824827 @default.
- Q65544175 P6153 Q507154 @default.
- Q65544175 P8363 Q78089383 @default.